| Literature DB >> 6684000 |
J Welsh, F Stuart, G Sangster, R Milstead, S Kaye, H Cash, D Charlton, K Calman.
Abstract
A dose-ranging study with oral levonantradol was performed in 20 cancer patients. The optimum oral dose which attenuated vomiting accompanying chemotherapy was 1 mg 4-hourly. Side-effects comprised dizziness, confusion, euphoria, drowsiness, and difficulty in concentrating. There was no cardiovascular toxicity. Overall toxicity appeared to be dose-related and was mild and acceptable.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6684000 DOI： 10.1007/bf00257422
Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333